Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real‐world data study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real‐world data study

Published:2021-05-13 Issue:8 Volume:37 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Lee Jiwoo¹,Kim Hwi Seung²³,Jung Chang Hee²³^ORCID,Park Joong‐Yeol²³,Lee Woo Je²³^ORCID

Affiliation:

1. Department of Internal Medicine Hallym University Dongtan Sacred Heart Hospital Hallym University College of Medicine Hwaseong Republic of Korea

2. Department of Internal Medicine Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

3. Asan Diabetes Center Asan Medical Center Seoul Republic of Korea

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3466

Reference27 articles.

1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

2. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

3. Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research

4. Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis

5. A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study;Diabetes Therapy;2024-03-01

2. Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy;Frontiers in Endocrinology;2022-06-17

3. The new dual gastric inhibitory peptide/glucagon‐like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?;Diabetes/Metabolism Research and Reviews;2021-10-15

4. Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations;Drugs;2021-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3